Troubling Vital Signs for Bright Health

The Bright Health team in sunnier days: its 2021 IPO Unable to deliver on enormous ambitions, Bright Health Group struggles to define a profitable course. O n paper, Bright Health Group was an investor’s dream. Led by experienced health insurance execs, the company promised a new approach. From early on, Bright touted a “narrow network” philosophy that worked closely with a small group of providers. The company’s target market wasn’t large employers or institutions; instead, it looked to sell individual health plans through the Affordable Care Act (ACA) exchanges, as well as Medicare Advantage plans for older Americans. Bright leaders heralded a new technology platform that would make the claims process easier for providers and patients alike. At its peak, Bright was valued at $11.2 billion, cementing its status as Minnesota’s first “unicorn” startup—a company valued at over $1 billion. It earned praise and recognition from startup boosters and investors, and even counted high-profile figures like Andy Slavitt, who ran Medicare and Medicaid in the Obama administration, on its board of directors. In a 2021 prospectus ahead of its eye-popping $924 million initial public offering that year, Bright noted that the company was serving more than 623,000 consumers across […]

You may also like...